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Comparison of Serum Spec fPLTM and 1,2-o-Dilauryl-Rac-Glycero-
3-Glutaric Acid-(6 0-Methylresorufin) Ester Assay in 60 Cats Using
Standardized Assessment of Pancreatic Histology
S. Oppliger, M. Hilbe, S. Hartnack, E. Zini, C.E. Reusch, and P.H. Kook
Background: Feline pancreas-speciﬁc lipase (Spec fPL) is considered a useful test for the antemortem diagnosis of pancre-
atitis in cats. A recent study found good agreement between the results of the Spec fPL and catalytic 1,2-o-dilauryl-rac-gly-
cero-3-glutaric acid-(60-methylresoruﬁn) ester (DGGR) lipase assay. Prospective studies evaluating their sensitivity and
speciﬁcity are lacking.
Objectives: To compare the results of the Spec fPL and the DGGR assays with a standardized histologic assessment of
the pancreas.
Animals: Sixty client-owned cats presented for necropsy.
Methods: Prospective study: Spec fPL concentrations and serum DGGR lipase activity were measured from the same
blood sample. The pancreas was removed within 3 hours after euthanasia; serial transverse sections were made every 0.5 cm
throughout the entire pancreas and reviewed using a histologic grading scheme. Sensitivity and speciﬁcity for the Spec fPL
and DGGR assay results were determined.
Results: The sensitivity and speciﬁcity for the Spec fPL assay (cutoﬀ value ≥5.4 lg/L) was 42.1 [95% conﬁdence interval
(95% CI), 29.4–55.9%] and 100% (95% CI, 31.0–100.0%). The sensitivity and speciﬁcity for the DGGR assay (cutoﬀ value
>26 U/L) was 36.8 (95% CI, 24.7–50.7%) and 100% (95% CI, 31.0–100.0%). When lymphocytic inﬂammation up to 10% of
a section was considered normal, the sensitivity and speciﬁcity for Spec fPL assay (cutoﬀ value ≥5.4 lg/L) was 61.1 (95% CI,
36.1–81.7%) and 69.0% (95% CI, 52.8–81.9%) and the sensitivity and speciﬁcity for the DGGR assay (cutoﬀ value >26 U/
L) was 66.7 (95% CI, 41.2–85.6%) and 78.6% (95% CI, 62.8–89.2%).
Conclusions and Clinical Importance: Both lipase assays performed similarly well, but their agreement with histologic pan-
creatic inﬂammation was limited.
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Histologic pancreatic inﬂammation appears to be acommon ﬁnding in cats1 with the consequence that
pancreatitis is also surmised to be a common clinical
disorder in cats. However, reports on clinically relevant
pancreatitis in cats are scarce2–4 and the actual preva-
lence of clinically relevant pancreatitis remains currently
unknown. Nonetheless, antemortem diagnosis continues
to be diﬃcult because of vague clinical signs and non-
speciﬁc clinicopathologic ﬁndings.4,5 Although ultra-
sonographic examination of the pancreas is an option
in many clinics, its sensitivity and speciﬁcity for the
diagnosis of feline pancreatitis are operator dependent
and therefore highly variable.3,6,7 Moreover, there is
poor agreement between serum lipase results and ultra-
sonographic ﬁndings that until recently were considered
to represent pancreatitis in cats.8 The commercially
available Spec fPL test, an enzyme-linked immunosor-
bent assay, is widely thought to be a useful test for
diagnosing pancreatitis in cats.9 However, details of its
development and validation have not been published in
a peer-reviewed article. More recently, a catalytic assay
for the determination of serum lipase activity using the
substrate 1,2-o-dilauryl-rac-glycero-3-glutaric acid-(60-
methylresoruﬁn)-ester (DGGR)10 was validated for use
in feline serum and has good agreement with the Spec
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fPL assay.11 The short turnaround time and low cost of
the DGGR assay are of particular beneﬁt to clinicians
and clients. Nevertheless, the results of the Spec fPL
and DGGR assay have not been compared to a gold
standard. Although the selection of a gold standard for
diagnosing pancreatitis in cats is controversial,9 histo-
logic examination of the pancreas currently constitutes
the only modality that allows a deﬁnitive diagnosis.
Therefore, the goal of this study was to compare the
results of the Spec fPL and DGGR assays with stan-
dardized histologic examination of the pancreas. We
hypothesized that the performance of both tests is simi-
lar for the diagnosis of pancreatitis in cats.
Materials and Methods
Animals and Study Design
A total of 60 cats that were euthanized for a variety of reasons
at the Clinic for Small Animal Internal Medicine, Vetsuisse Fac-
ulty, University of Zurich and subsequently submitted for
necropsy were used in the study. Collection of a serum sample
within 12 hours before euthanasia, and removal of the entire pan-
creas from each cat within 3 hours of euthanasia were criteria for
inclusion in the study. Pancreata were placed in 10% buﬀered for-
malin, and the Spec fPL concentration and serum lipase activity
using the DGGR assay were measured in the same blood sample.
Serum Lipase Determination
Serum lipase activity was measured within one hour using the
DGGR assay.a Spec fPL concentration was measured by IDEXX
Laboratories.b The reference interval for the DGGR assay (8–
26 U/L) was previously established using 80 clinically healthy,
male and female cats of various breeds.11
Histologic Evaluation
Each pancreas was cut transversely at the midpoint of the body
yielding a left and right side, which were cut transversely into
smaller pieces (Fig 1). Serial transverse sections of the entire pan-
creas were made every 0.5 cm and stained with hematoxylin and
eosin. Light microscopy was used for examination of all sections
by a board-certiﬁed pathologist (MH) in a blinded fashion.6 A his-
tologic scoring scheme was designed and modiﬁed based on previ-
ously reported scoring schemes.1,12 All tissue sections of the
pancreas were evaluated for the presence of neutrophilic inﬂamma-
tion, lymphocytic inﬂammation, pancreatic edema, pancreatic
necrosis, peripancreatic fat necrosis, ﬁbrosis, cystic degeneration,
atrophy, nodular hyperplasia, islet cell amyloidosis, and neoplasia.
The severity of lesions (with the exception of neoplasia) in each
section was scored as follows: 0 = 0% of the section aﬀected,
grade 1 = <25% of the section aﬀected, grade 2 = 25–50% of the
section aﬀected, and grade 3 = >50% of the section aﬀected.
Because mild lymphocytic inﬂammation (Fig 2) has been shown to
be a common ﬁnding in feline pancreata,1 additional statistical
analyses were carried out with 0–10% lymphocytic inﬂammation
deﬁned as absence of lymphocytic inﬂammation, and grade 1
deﬁned as 10–25% of the section aﬀected. For each variable, a
mean cumulative score (MCS) was calculated as MCS = ∑ score
of single sections/number of sections. A disease activity index (AI)
was calculated as AI = (MCSneutrophilic inﬂammation + MCSlymphocytic
inﬂammation + MCSpancreatic edema + MCSpancreatic necrosis + MCSfat
necrosis)/5. The right and left side of the pancreas were compared.
Statistical Analyses
A commercial softwarec was used for statistical analysis.
Cohen’s kappa coeﬃcient (j) was calculated to measure agreement
between Spec fPL and DGGR assays and between both lipase
assays and histologic results. Diﬀerences in MCS, AI, and CI of
the right and left side of the pancreas were evaluated using the
Wilcoxon signed-rank test. Bonferroni correction was applied to
multiple comparisons. The performance of both lipase assays was
evaluated using Receiver operating characteristic (ROC) curves
and the corresponding area under the curve (AUC). For the calcu-
lation of Cohen’s Kappa, ROC-Curve, and sensitivity and speci-
ﬁcity, the AI was dichotomized into AI = 0 (no evidence of
histologic pancreatic inﬂammation) and AI > 0 (evidence of histo-
logic pancreatic inﬂammation). In addition, logistic regressions
with either SpecfPL or DGGR assay as predictors were performed
to assess which one showed a better model ﬁt based on AIC
(Akaike’s information criterion). Logistic regression analysis was
performed for the original AI [AI = 0 (no evidence of histologic
pancreatic inﬂammation) and AI > 0 (evidence of histologic
Fig 1. A specimen of feline pancreas that has been ﬁxated in for-
malin and cut transversely every 0.5 cm.
Fig 2. Small nests of lymphocytes located predominantly perivas-
cularly in the pancreas of a cat. The overall grade of lymphocytic
inﬂammation in the corresponding slide was graded as 0–10%.
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pancreatic inﬂammation)] as well as for the modiﬁed AI when the
presence of up to 10% lymphocytes was considered normal. We
utilized AIC as a goodness-of-model ﬁt with lower values (<2)
indicating a better model ﬁt.
Results
Study Population
The study population consisted of 60 cats that
included 30 male (30 neutered) and 30 female (28
spayed) cats, ranging in age from 10 months to 19 years
(median 11.5). Breeds included domestic shorthair
(n = 46), domestic longhair (n = 3), Persian (n = 3),
Siberian (n = 2), Angora (n = 1), British longhair
(n = 1), British shorthair (n = 1), Ragdoll (n = 1), Sia-
mese (n = 1), and mixed breed cats (n = 1).
Lipase Assay Results
The Spec fPL concentration was ≤3.5 lg/L in 30/60
(50%) cats, 3.6–5.3 lg/L in 6/60 (10%) cats, and
≥5.4 lg/L in 24/60 (40%) cats. Serum lipase activity
was ≤26 U/L in 39/60 (65%) cats and ≥27 U/L in 21/60
(35%) cats (Table 1). Agreement between the Spec fPL
(cutoﬀ value >3.5 lg/L) and DGGR assays (cutoﬀ
value >26 U/L) was j = 0.63 (standard error [SE],
0.10), and agreement between the Spec fPL (cutoﬀ value
≥5.4 lg/L) and DGGR assays (cutoﬀ value >26 U/L)
was j = 0.82 (SE, 0.08).
Pancreatic Histology
The mean number of sections was 15.43 (range, 9–22)
per formalin-ﬁxated pancreas with 6.78 (range, 3–10)
for the right side and 8.65 (range, 3–13) for the left side
of the pancreas. The mean length of the right side of
the formalin-ﬁxated pancreas was 6.87 cm (range, 1.50–
8.50 cm) and the mean length of the left formalin-
ﬁxated side was 8.51 cm (range, 2.0–9.50 cm). Nodular
hyperplasia was the most common histopathologic ﬁnd-
ing and was seen in 57/60 (95%) cats, followed by lym-
phocytic inﬂammation in 56/60 (93%), cystic
degeneration in 43/60 (72%), ﬁbrosis in 37/60 (62%),
islet cell amyloidosis in 26/60 (43%), atrophy in 16/60
(27%), neutrophilic inﬂammation in 11/60 (18%),
edema in 9/60 (15%), peripancreatic fat necrosis in 9/60
(15%), neoplasia in 9/60 (16%) (5 lymphoma, 3 adeno-
carcinoma, and 1 mastocytoma), and pancreatic necro-
sis in 8/60 (13%). The numbers of cats with pancreatic
lesions and the type of lesions are shown in Tables 2
and 3. Detailed results of the cats with pancreatitis and
neoplasia (AI, MCS for neutrophilic and lymphocytic
inﬂammation, edema, necrosis, as well as results of Spec
fPL and DGGR assay) are available in Table S1. There
were no signiﬁcant diﬀerences in the MCS between the
right and left sides of the pancreas with regard to neu-
trophilic inﬂammation (P = .053), lymphocytic inﬂam-
mation (P = .142), edema (P = .612), pancreatic
necrosis (P = .161), peripancreatic fat necrosis
(P = .594), ﬁbrosis (P = .202), cystic degeneration (P =
.139), atrophy (P = .414), nodular hyperplasia (P =
.28), and islet cell amyloidosis (P = .269).
The mean AI was 0.19 (SD, 0.25; range, 0.00–1.12).
The AI was 0 in 3/60 (5%) cats, >0 but <1 in 55/60
(92%) cats, and >1 in 2/60 (3%) cats. The AI did not
diﬀer signiﬁcantly between the right and left sides of the
pancreas (P = .7).
When normal pancreas was considered to include up
to 10% lymphocytic inﬂammation, the AI was 0 in 42/
60 (70%) cats, >0 but <1 in 17/60 (28%) cats, and >1 in
1/60 (2%) cats, and the mean AI was 0.10 (SD, 0.26;
range, 0.00–1.06). The AI did not diﬀer signiﬁcantly
between the right and left sides of the pancreas
(P = .124).
Agreement Between Lipase Assay Results and
Pancreatic Histology
Agreement between AI and the results of the Spec
fPL assay (cutoﬀ value >3.5 lg/L) was slight (j = 0.10;
SE, 0.06). Agreement between AI and the results of the
Spec fPL assay (cutoﬀ value ≥5.4 lg/L) was slight
(j = 0.07; SE, 0.04), and agreement between AI and the
results of the DGGR assay (cutoﬀ value >26 U/L) was
also slight (j = 0.06; SE, 0.03).
When normal pancreas was considered to include up
to 10% lymphocytic inﬂammation, agreement between
AI and the results of the Spec fPL assay (cutoﬀ value
>3.5 lg/L) was slight (j = 0.13; SE, 0.12), and agree-
ment between AI and the results of the Spec fPL assay
(cutoﬀ value ≥5.4 lg/L) was fair (j = 0.28; SE, 0.13).
Agreement between AI and the results of the DGGR
assay (cutoﬀ value >26 U/L) was moderate (j = 0.43;
SE, 0.12).
Logistic Regression Analysis
Based on AIC, as a goodness-of-ﬁt-criterion, the
models with the DGGR assay indicated a better model
Table 1. Contingency table showing the frequency dis-
tribution of the results of the Spec fPL and DGGR-
lipase assays using diﬀerent cut-oﬀ values.
Spec fPL
≤3.5 lg/L 3.6–5.3 lg/L ≥5.4 lg/L Total
DGGR-lipase
≤26 U/L 29 6 4 39
≥27 U/L 1 0 20 21
Total 30 6 24 60
Table 2. Frequency distribution of cats with neu-
trophilic and lymphocytic inﬂammation of the pancreas
of diﬀerent grades.
Histologic variable 0% <10% 10–25% 25–50% >50%
Neutrophilic
inﬂammation
49 7 2 2 0
Lymphocytic
inﬂammation
4 51 3 1 1
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ﬁt compared to SpecfPL for both, the original AI
(DGGR assay: 67.4 versus SpecfPL: 88) as well as the
modiﬁed AI when up to 10% lymphocytic inﬂammation
was considered normal (DGGR assay: 75.7 versus
SpecfPL: 91.17).
ROC Curve of Lipase Assays Versus AI as Gold
Standard
Receiver operating characteristic curves of both lipase
assays are shown in Figure 3; the gold standard used
was an AI for which up to 10% lymphocytic inﬂamma-
tion was considered normal. The AUC for the Spec fPL
assay was 0.60 [95% conﬁdence interval (95% CI),
0.40–0.80] and the AUC for the DGGR assay was 0.71
(95% CI, 0.55–0.88).
Sensitivity and Specificity
When the AI was used as the gold standard, the sen-
sitivity and speciﬁcity of the Spec fPL assay (cutoﬀ
value >3.5 lg/L) were 52.6% (95% CI, 39.1–65.8%)
and 100.0% (95% CI, 31.0–100.0%). The sensitivity
and speciﬁcity of the Spec fPL assay (cutoﬀ value
≥5.4 lg/L) were 42.1% (95% CI, 29.4–55.9%) and
100.0% (95% CI, 31.0–100.0%). The sensitivity and
speciﬁcity of the DGGR assay were 36.8% (95% CI,
24.7–50.7%) and 100.0% (95% CI, 31.0–100.0%).
When the AI was used as the gold standard and up
to 10% lymphocytic inﬂammation was considered nor-
mal, the sensitivity and speciﬁcity of the Spec fPL assay
(cutoﬀ value >3.5 lg/L) were 61.1% (95% CI, 36.1–
81.7%) and 54.8% (95% CI, 38.8–69.8%). The sensitiv-
ity and speciﬁcity of the Spec fPL assay (cutoﬀ value
≥5.4 lg/L) were 61.1% (95% CI, 36.1–81.7%) and
69.0% (95% CI, 52.8–81.9%). The sensitivity and speci-
ﬁcity of the DGGR assay were 66.7% (95% CI, 41.2–
85.6%) and 78.6% (95% CI, 62.8–89.2%).
Discussion
This study compares the results of an immunoassay
and a catalytic lipase assay with those of standardized
histologic examination of the pancreas in cats. There
was very good agreement between the lipase assays,
which was similar to the results of our previous studies
using diﬀerent populations of cats.8,11 In this study, the
sensitivity of the Spec fPL assay with a cutoﬀ value of
≥5.4 lg/L for the diagnosis of pancreatic inﬂammation
ranged from 42.1% to 61.1%, while the DGGR-lipase
assay had a sensitivity of 36.8–66.8%. The speciﬁcity of
the Spec fPL assay with a cutoﬀ value of ≥5.4 lg/L ran-
ged from 69.0 to 100%, whereas that of the DGGR
assay was 78.6 to 100%; the value depended on whether
up to 10% lymphocytic inﬂammation was considered
normal or abnormal. A recent retrospective study
reported similar sensitivities and speciﬁcities for the
Spec fPL (57% sensitivity, 63% speciﬁcity) and DGGR
assays (48% sensitivity, 63% speciﬁcity) in 31 cats.
However, histopathologic evaluation was based on pan-
creatic tissue obtained during necropsy (28) or biopsy
(3),11 and the time interval between histopathologic
evaluation and lipase measurements in that study ran-
ged from a couple of hours to 5 days.
Based on our scoring system, 57 of 60 cats had pan-
creatic inﬂammation, which was equivalent to a preva-
lence of 95%. This is even higher than the results of the
largest histopathologic study to date, in which the
prevalence of pancreatitis in a comparable cat popula-
tion was 67%.1 However, that study did not specify
how many sections per pancreas were examined. It is
conceivable that the overall prevalence of pancreatic
inﬂammation increases when the organ is sectioned at
closer intervals because fewer lesions would remain
undetected. Similarly, a recent study in dogs reported
histopathologic evidence of pancreatitis in 63 of 70
dogs.13
The relevance of mild lymphocytic pancreatic inﬂam-
mation in cats is currently unknown. In a study that
evaluated the feline pancreatic lipase immunoreactivity
(fPLI) test, small nests of lymphocytes were considered
normal in feline pancreata.6 We therefore decided to
Table 3. Frequency distribution of cats with pancre-
atic lesions of diﬀerent grades.
Histologic variable 0% 1–25% 25–50% >50%
Edema 51 5 4 0
Pancreatic necrosis 52 6 2 0
Fat necrosis 51 5 4 0
Fibrosis 23 30 5 2
Cystic degeneration 17 39 4 0
Atrophy 44 10 5 1
Nodular hyperplasia 3 42 10 5
Islet cell amyloidosis 34 18 2 6
Fig 3. ROC curve for the histopathologic diagnosis of pancreati-
tis by use of the Spec fPL assay (solid line) and the DGGR assay
(dashed line). The gold standard was an AI with up to 10% lym-
phocytic inﬂammation deﬁned as normal.
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establish an alternative AI that deﬁned lymphocytic
inﬂammation aﬀecting <10% of a section as normal.
Subsequently, the sensitivity of the Spec fPL assay (cut-
oﬀ value ≥5.4 lg/L) increased from 42.1 to 61.1%
because more cats with normal lipase results were classi-
ﬁed as healthy. This was slightly lower than the sensitiv-
ity of 67% reported for the fPLI assay in the study
mentioned above.6 Likewise, the sensitivity of the
DGGR assay increased from 36.5 to 78.6%, making it
the test with the highest sensitivity in this study. It has
been argued that a diagnostic test with a maximal sensi-
tivity might not be an absolute priority because clinical
signs compatible with pancreatitis may be already
detected in an initial clinical assessment and thus could
be viewed as some sort of screening test.14 Rather, a
true diagnostic test would be needed to conﬁrm the sus-
picion of pancreatitis, and the clinician would thus be
interested in a test with maximal speciﬁcity rather than
maximal sensitivity.14 While these considerations might
relate to the diagnosis of pancreatitis in dogs, we feel
that a test with a high sensitivity is more useful in cats
because signs of pancreatitis in this species are vague
and nonspeciﬁc.
The speciﬁcity of both lipase assays was 100% when
mild lymphocytic inﬂammation (<10% of section
aﬀected) was considered to be indicative of pancreatitis.
Because only 3 cats were classiﬁed as healthy in this
study, calculation of speciﬁcity was based on a small
number of cases, reﬂected in the wide 95% CI of 31.0–
100.0%. A speciﬁcity of 100% was also reported for the
fPLI assay in a study that used 8 healthy shelter cats.6
When we considered lymphocytic inﬂammation in
<10% of the section as normal, the number of healthy
cats increased to 42 and the speciﬁcity decreased to
61.1% for the Spec fPL assay (cutoﬀ value ≥5.4 lg/L)
and to 66.7% for the DGGR assay. Because the signiﬁ-
cance of minimal to mild lymphocytic inﬂammation is
not known, we are unable to conclude which calcula-
tion of speciﬁcity better reﬂects clinical pancreatitis.
The performance of the Spec fPL and DGGR assays
was similar based on the agreement of results, areas
under the curve, and sensitivity. The DGGR assay had
a slightly higher speciﬁcity, which must be interpreted
cautiously because of overlapping conﬁdence intervals.
It is often stated that serum lipase activity is not pan-
creas-speciﬁc, implying that sensitivity is higher because
of extrapancreatic sources of lipase, and speciﬁcity
lower compared with the pancreas-speciﬁc Spec fPL
assay. In human medicine, the DGGR assay is generally
considered to be speciﬁc for pancreatic lipase; several
cofactors such as colipase, bile salts, and calcium ions
play an important role in the activation process of pan-
creatic lipase, thus increasing the assay’s speciﬁcity.10,15
The high speciﬁcity of the DGGR assay in this study
suggests that this also applies to cats. Another possible
explanation is that extrapancreatic serum lipase activi-
ties were coincidentally normal in this study population,
but because the cats were included irrespective of the
cause of euthanasia, this seems unlikely.
The reference interval for the Spec fPL assay (0–
3.5 lg/L) was established using 41 healthy cats several
years ago.d The cutoﬀ value of ≥5.4 lg/L was based on
141 cats with “clinical signs consistent with pancreati-
tis.”d Two internists blinded to the Spec fPL results
divided the 141 cats into 6 groups with diﬀerent proba-
bilities of having pancreatitis based on history, the
results of clinical examination, CBC, biochemistry
panel, urinalysis, and abdominal ultrasonography, and
clinical outcome.d This was an innovative approach
because, normally, establishment of the reference inter-
val is based only on healthy individuals and does not
allow a deﬁnitive statement about the condition of indi-
viduals with increased values. However, the data are
only available as an abstract and thus we do not know
whether the cats had acute or chronic pancreatitis or,
perhaps more importantly when considering the often
unspeciﬁc clinical picture of feline pancreatitis, how
much importance was placed on the results of ultra-
sonography, which has since been shown to have poor
agreement with Spec fPL results.8 On the other hand,
there is only one reference interval available for the
DGGR assay (8–26 U/L).11 In a study of 251 cats with
suspicion of pancreatitis, the best agreement between
the Spec fPL and DGGR assay was seen with cutoﬀ
values of ≥5.4 lg/L for Spec fPL and >34 U/L for the
DGGR assay.11 However, in the course of the statistical
evaluation, we checked this possible cutoﬀ value and
could not ﬁnd a better agreement with the Spec fPL
cutoﬀ of ≥5.4 lg/L nor with the AI compared with the
cutoﬀ value of >26 U/L for the DGGR assay. Based on
the results of this study, we were unable to determine
whether there is a DGGR assay cutoﬀ value that is
more consistent with pancreatitis than the reference
interval used in this study.
We chose to include cats with concurrent pancreatic
neoplasia because those cases also had pancreatitis. To
the authors’ knowledge, there are no previous reports
on the results of serum lipase measurements in cats with
pancreatic neoplasia. A previous study in dogs using an
assay that contained 1,2-diglyceride as a substrate sug-
gested that marked hyperlipasemia may be a noninva-
sive marker for pancreatic neoplasia.16 However, this
does not seem to be the case based on these results; the
values for the lipase assays, which were similar to the
AI, did not discriminate between spontaneous pancre-
atitis and inﬂammation secondary to neoplastic growth
in the pancreas.
The value of histopathology as a gold standard for
the diagnosis of feline pancreatitis has been debated.9,17
The two main limitations of histopathology are the pos-
sibility of false negative results because of missed lesions
and the unknown clinical signiﬁcance of pancreatic
lesions. Because we evaluated all serially sectioned pan-
creata in a standardized fashion, the chances of missing
lesions were lower than routine pancreatic biopsy.
Because the clinical relevance of histopathologic lesions
is frequently discussed in relation to feline pancreatitis,
it is important to note that cats often present with con-
current inﬂammation in the liver, pancreas, and intesti-
nes (i.e. triaditis).18,19 Clinical signs of cholangitis,
pancreatitis, and enteritis are nearly impossible to dis-
tinguish, and it therefore seems almost pointless to try
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to attribute histopathologic ﬁndings of the pancreas to
the corresponding clinical signs in the individual
patient. Experimentally-induced pancreatitis might
address this problem; however, not only would this be
unethical but also it is questionable whether experimen-
tally-induced pancreatitis reﬂects the clinical and patho-
logic ﬁndings of spontaneous pancreatitis. Despite its
shortcomings, histopathology remains the most deﬁni-
tive diagnostic tool, and it is the authors’ opinion that
it is the best gold standard currently available for
assessing feline pancreatic disease.
Our study had some limitations. Although the num-
ber of cats comprised the largest study population to
date, 60 cats are a relatively small number for statistical
evaluations, which are reﬂected in the relatively wide
95% CI in the calculation of sensitivity and speciﬁcity.
All cats were terminally ill, which may have created to
a bias toward a more severely diseased population.
However, the same limitation would apply to the most
frequently cited study characterizing feline pancreatitis
by DeCock et al, making the histopathology results of
the two studies comparable.1 The time interval between
measurement of serum lipase and euthanasia of the cats
was a maximum of 12 hours, which may be considered
a further limitation. The onset of new pancreatic lesions
during this time interval is possible and could theoreti-
cally explain some of the discrepancy between lipase
results and histologic ﬁndings.
For the calculation of Cohen’s kappa values and sen-
sitivity and speciﬁcity, it was necessary to dichotomize
(i.e. normal versus increased) the results of the AI and
the serum lipase determinations. It is possible that this
type of allocation of continuous scale values might
underestimate a relationship in the dataset. Most proba-
bly, it is more realistic to look at Spec fPL and DGGR
lipase activites as continuous variables that are surro-
gates for the degree of pancreatic cellular injury, than
to dichotomize a test to absence or presence of disease.
However, if we had not dichotomized test results we
would have used an interpretation diﬀerent from the
cut oﬀs provided by the manufacturere and currently
used in clinical practice. To address this dilemma, we
have added a logistic regression analysis (and AIC as a
model selection criterion) in order to assess if AI 0 or 1
is better explained by variations in SpecfPL or the
DGGR assay. Thus, giving the reader some idea
whether SpecfPL or DGGR assay is closer linked to
AI. Results indicate that the DGGR assay performs
better than SpecfPL in terms of explaining the variabil-
ity in the AI.
In summary, both lipase assays had a similar perfor-
mance when compared to pancreatic histology. We feel
that the DGGR assay is at least as useful as the Spec fPL
assay and certainly more advantageous when cost is con-
sidered. Our results also indicate that it is impossible to
use the results of a blood test for determining the pres-
ence or absence of pancreatitis without harvesting the
whole pancreas in cats. Even when the entire pancreas is
harvested, interpretation of diagnostic blood test results
remains diﬃcult because of the unknown relevance of
minor histopathologic changes in the pancreas. Internists
as well as manufacturers of diagnostic tests should
acknowledge this shortcoming and be more cautious in
their wording of speciﬁc test information.
Footnotes
a Lipase colorimetric for Roche Cobas Integra 800; Roche Diag-
nostics, Rotkreuz, Switzerland)
b IDEXX GmbH Ludwigsburg, Germany
c IBM SPSS v.21 for Mac OS X; IBM Corporation, New York, NY
d Forman MA, Shiroma J, Armstrong PJ, Robertson JE, Buch J,
(2009). Evaluation of Feline Pancreas-Speciﬁc Lipase (Spec
fPLTM) for the Diagnosis of Feline Pancreatitis. [ACVIM
Abstract 165]. J Vet Intern Med 2009; 23: 733–734 (abstract)
e http://vetmed.tamu.edu/gilab/service/assays/pli
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